Endothelial cell function and vascular inflammatory signaling

Endothelial cell function and vascular inflammatory signaling refers to the integrated physiological processes that maintain the health of the vascular lining and the pathological shifts that drive cardiovascular disease. The endothelium acts as a dynamic endocrine organ, regulating vascular tone through the production of nitric oxide and managing leukocyte trafficking via the expression of adhesion molecules like VCAM-1 and ICAM-1. In response to stressors such as oxidized LDL or pro-inflammatory cytokines (e.g., TNF-alpha, IL-1beta), the endothelium undergoes 'activation,' a state characterized by increased permeability, pro-thrombotic activity, and the recruitment of immune cells. This transition to endothelial dysfunction is a critical early step in the development of atherosclerosis and hypertension. Therapeutic intervention in this pathway involves a diverse range of agents, from statins and ACE inhibitors that improve nitric oxide bioavailability to targeted biologics like canakinumab that inhibit specific inflammatory mediators. While modulating these pathways offers significant potential for reducing major adverse cardiovascular events, it also presents challenges such as systemic immunosuppression and the need for precise patient selection using biomarkers like hsCRP.

Other names

Endothelial dysfunctionVascular inflammationEndothelial activationVascular homeostasisEndothelial-to-mesenchymal transition

Modulation of endothelial nitric oxide synthase (eNOS) activity to increase nitric oxide bioavailability, inhibition of pro-inflammatory transcription factors such as NF-kappaB, reduction of cell surface adhesion molecule expression (e.g., ICAM-1, VCAM-1), and direct blockade of pro-inflammatory cytokines like IL-1beta and IL-6.